D4-GDI Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5100123-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA5100123 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
D4-GDI
Classification
Polyclonal
Conjugate
Unconjugated
Gene
ARHGDIB
Gene Alias
ARHGDIB; D4; d4 gdi; GDI LYGDI; GDIA2; GDID4; LYGDI; Ly-GDI; RAP1GN1; Rho GDI 2; Rho GDP dissociation inhibitor (GDI) beta; Rho GDP dissociation inhibitor beta; rho GDP-dissociation inhibitor 2; Rho, GDP dissociation inhibitor (GDI) beta; rho-GDI beta; RhoGDI2
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
11857, 362456, 397
Content And Storage
-20°C
Form
Liquid
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.
P52566, Q61599
Gene Symbols
ARHGDIB
Immunogen
A synthesized peptide derived from human ARHGDIB(Accession P52566), corresponding to amino acid residues E3-L53.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Antibody detects endogenous levels of total ARHGDIB
- Acts as a ventralizing factor during embryogenesis
- Inhibits axin-mediated JNK activation by binding axin and disrupting axin homodimerization
- This in turn antagonizes a Wnt/beta-catenin-independent dorsalization pathway activated by AXIN/JNK-signaling.